CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Heparin Sodium Injection
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2017-11-14. Latest FDA row update: 2026-10-02.
FDA lists 8 package records, with companies: B. Braun Medical Inc., Baxter Healthcare, Baxter Healthcare Corporation, Fresenius Kabi USA, LLC, Hospira, Inc., Hospira, Inc., a Pfizer Company. Package NDCs: 0264-9872-00, 0264-9872-10, 0338-0431-03, 0338-0433-04, 0409-1005-20, 0409-2222-12, 63323-519-10, 63323-519-77.
FDA shortage reason: Other
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| B. Braun Medical Inc. | 0264-9872-10 | Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-10) | Limited Availability | 2026-09-22 |
| B. Braun Medical Inc. | 0264-9872-00 | Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-00) | Limited Availability | 2026-09-22 |
| Baxter Healthcare | 0338-0431-03 | Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03) | Available | 2026-10-02 |
| Baxter Healthcare | 0338-0433-04 | Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04) | Available | 2026-10-02 |
| Fresenius Kabi USA, LLC | 63323-519-10 | Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10) | Available | 2026-09-15 |
| Fresenius Kabi USA, LLC | 63323-519-77 | Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77) | Unavailable | 2026-09-15 |
| Hospira, Inc., a Pfizer Company | 0409-1005-20 | Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-1005-20) | Available | 2026-09-22 |
| Hospira, Inc., a Pfizer Company | 0409-2222-12 | Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-2222-12) | Available | 2026-09-22 |
Source facts
Grouped generic ingredient: Heparin Sodium Injection · 8 package records
Therapeutic categories: Hematology
Dosage forms: Injection
Routes: INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.